When Sandoz stopped distributing the generic formulation for the heartburn drug Zantac, also known as ranitidine, it was because the FDA and European regulators learned about a link between this medication and the potentially dangerous chemical, NDMA (scientific name N-Nitroso-dimethylamine).
“The FDA reported that the levels of N-nitrosodimethylamine (NDMA) in ranitidine in preliminary tests barely exceed amounts found in common foods,” Sanofi, the company responsible for Zantac, said in a statement.
Ranitidine is a very common over-the-counter stomach acid blocker that is widely prescribed to babies, adults, and the elderly. It has not been recalled, but Sandoz is not sending the medication out to stores.
What is NDMA?
NDMA is a chemical found in both industrial and natural processes. It is classified as a probable carcinogen –a cancer-causing chemical — according to the Environmental Protection Agency. NDMA acts as a carcinogen “because it modifies your DNA,” Dr. William Mitch, a professor of civil and environmental engineering and wastewater expert at Stanford University, said in an interview with ABC news.
A customer service specialist at Sandoz stated, “NDMA has been shown to increase cancer risk in animal experiments while NDMA has been shown to increase cancer risk in animal experiments, there is no consistent evidence as to how much this substance may potentially increase cancer risk in humans.”
(MORE: High levels of cancer-causing chemical found in mint and menthol e-cigarettes: Study)
Does ranitidine, a medication given to babies, contain NDMA?
Drew Angerer/Getty Images
Packages of Zantac sit on a shelf at a drugstore, Sept. 19, 2019, in New York.
“We do not know for sure,” Mitch said. The leading theory is that enzymes in the body react with ranitidine to create NDMA. Studies from Stanford by Mitch and his team, show that people who take ranitidine have high levels of NDMA in their urine, suggesting that it is created in the body.
Why is this news now?
The distribution decision by Sandoz only recently happened, but people are concerned that ranitidine has been on the market for years. “If the levels of NDMA is that high, have we missed or not seen the cancer?” asked Dr. Jon Ernstoff, a gastroenterologist.
Academics have recently focused on potential sources of NDMA, as the levels of NDMA in wastewater are rising. As common blood pressure medications were implicated earlier this year, a handful of pharmacies have been on higher alert to test their medications.
“We are working closely with the FDA and are conducting our own robust investigations to ensure we continue to meet the highest quality safety and quality standards,” Sanofi said in a statement.
How do you know if you have been affected?
The health effects of overexposure to NDMA include jaundice, nausea, fever, vomiting, abdominal cramps and dizziness. High levels of exposure can cause reduced function of the kidneys and lungs. Please talk to your doctor if you are on ranitidine and experience these side effects. Medical research needs data. “We need to see cause and effect. That has not been done yet,” Ernstoff said in response to concerns about ranitidine, NDMA and cancer.
(MORE: FDA warns against drinking Mineral Miracle Solution, says it’s ‘the same as bleach’)
Should you stop taking ranitidine?
“I don’t think it’s a panic situation for most people,” Ernstoff said. “The public should be aware that there are alternatives. Other medications are equally effective.”
At this time, the FDA and European regulatory agencies are not telling people to stop taking Zantac, if prescribed by their doctors. Please talk to your doctor if you have concerns about ranitidine. Sandoz has removed its products while Sanofi has not.
Sanofi said, “there are currently no plans to stop distributing or manufacturing Zantac or other ranitidine products outside of Canada.”
The “precautionary release and distribution stop for all our Sandoz ranitidine-containing medicines in all our markets will remain valid until further clarification. We are in close contact with the health authorities,” the company said in a statement.